424792-57-4Relevant articles and documents
GPR119 Receptor Agonists
-
Page/Page column 18, (2009/12/05)
Provided herein are compounds of the formula (I): as well as pharmaceutically acceptable salts thereof, wherein the substituents are as those disclosed in the specification. These compounds, and the pharmaceutical compositions containing them, are useful for the treatment of metabolic diseases and disorders such as, for example, type II diabetes mellitus.
SYNTHESIS OF METHYLSULPHONYL BENZENE COMPOUNDS
-
Page/Page column 8-9; 10-11, (2010/11/27)
The present invention relates to a process for the synthesis of l-substituted-2-fluoro-4- methylsulfonylphenyl compounds.
BENZAMIDE DERIVATIVES THAT ACT UPON THE GLUCOKINASE ENZYME
-
Page/Page column 73, (2010/11/08)
Compounds of Formula: (I); wherein: R1 is hydroxymethyl; R2 is selected from -C(O)NR4R5, SO2NR4R5, S(O)pR4 and HET-2; HET-1 is a 5- or 6-membered, optionally substitut